Literature DB >> 26303340

Adenosine A₂A receptors permit mGluR5-evoked tyrosine phosphorylation of NR2B (Tyr1472) in rat hippocampus: a possible key mechanism in NMDA receptor modulation.

Konstantinos Sarantis1, Eirini Tsiamaki1, Stylianos Kouvaros1, Costas Papatheodoropoulos1, Fevronia Angelatou1.   

Abstract

A great body of evidence points toward a functional interaction between metabotropic glutamate 5 receptors (mGluR5) and NMDA receptors (NMDAR) that enhances synaptic plasticity and cognition. However, the molecular mechanism underlying this interaction remains unclear. Here, we show that co-activation of mGluR5 and NMDAR in hippocampal slices synergistically leads to a robust phosphorylation of NR2B (Tyr1472), which is Src kinase dependent and is enabled by endogenous adenosine acting on A2A receptors. As it is well known, NR2B (Tyr1472) phosphorylation anchors NR2B-containing NMDARs to the surface of post-synaptic membranes, preventing their internalization. This is supported by our electrophysiological experiments showing that co-activation of mGluR5 and NMDARs robustly enhances NMDAR-dependent neuronal excitability recorded in CA1 hippocampal region, which temporally coincides with the robust increase in NR2B (Tyr1472) phosphorylation, depends on Src kinases and is also permitted by A2A receptors. Thus, we strongly suggest that NR2B (Tyr1472) phosphorylation constitutes, at least to some extent, the molecular mechanism underlying the mGluR5-mediated enhancement of NMDAR-dependent responses, which is modulated by A2A receptors. A better understanding of the molecular basis of mGluR5/NMDAR interaction would elucidate their role in synaptic plasticity processes as well as in pathological conditions. We propose the following molecular mechanism by which metabotropic Glutamate Receptor 5 (mGluR5) potentiate ionotropic Glutamate N-Methyl-D-Aspartate Receptor (NMDAR) responses in rat hippocampus. Co-activation of mGLUR5/NMDAR activates Src kinases, leading to NR2B(Tyr1472) phosphorylation, which anchors NR2B-containing NMDAR to the plasma membrane, thus inducing a robust increase in the NMDA-dependent excitability. Interestingly, adenosine A2A receptors license the mGluR5-induced NR2B(Tyr1472) phosphorylation.
© 2015 International Society for Neurochemistry.

Entities:  

Keywords:  NR2B; Src kinases; adenosineA2AR; hippocampus; mGluR5; phosphorylation

Mesh:

Substances:

Year:  2015        PMID: 26303340     DOI: 10.1111/jnc.13291

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  19 in total

1.  α-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B.

Authors:  Diana G Ferreira; Mariana Temido-Ferreira; Hugo Vicente Miranda; Vânia L Batalha; Joana E Coelho; Éva M Szegö; Inês Marques-Morgado; Sandra H Vaz; Jeong Seop Rhee; Matthias Schmitz; Inga Zerr; Luísa V Lopes; Tiago F Outeiro
Journal:  Nat Neurosci       Date:  2017-09-25       Impact factor: 24.884

2.  Targeted neurogenesis pathway-based gene analysis identifies ADORA2A associated with hippocampal volume in mild cognitive impairment and Alzheimer's disease.

Authors:  Emrin Horgusluoglu-Moloch; Kwangsik Nho; Shannon L Risacher; Sungeun Kim; Tatiana Foroud; Leslie M Shaw; John Q Trojanowski; Paul S Aisen; Ronald C Petersen; Clifford R Jack; Simon Lovestone; Andrew Simmons; Michael W Weiner; Andrew J Saykin
Journal:  Neurobiol Aging       Date:  2017-08-18       Impact factor: 4.673

Review 3.  Bioactive human Alzheimer brain soluble Aβ: pathophysiology and therapeutic opportunities.

Authors:  Shaomin Li; Andrew M Stern
Journal:  Mol Psychiatry       Date:  2022-04-28       Impact factor: 15.992

4.  Caffeine has a dual influence on NMDA receptor-mediated glutamatergic transmission at the hippocampus.

Authors:  Robertta S Martins; Diogo M Rombo; Joana Gonçalves-Ribeiro; Carlos Meneses; Vladimir P P Borges-Martins; Joaquim A Ribeiro; Sandra H Vaz; Regina C C Kubrusly; Ana M Sebastião
Journal:  Purinergic Signal       Date:  2020-10-06       Impact factor: 3.765

5.  Physiological activation of mGlu5 receptors supports the ion channel function of NMDA receptors in hippocampal LTD induction in vivo.

Authors:  Kenneth J O'Riordan; Neng-Wei Hu; Michael J Rowan
Journal:  Sci Rep       Date:  2018-03-13       Impact factor: 4.379

Review 6.  The Influence of Na(+), K(+)-ATPase on Glutamate Signaling in Neurodegenerative Diseases and Senescence.

Authors:  Paula F Kinoshita; Jacqueline A Leite; Ana Maria M Orellana; Andrea R Vasconcelos; Luis E M Quintas; Elisa M Kawamoto; Cristoforo Scavone
Journal:  Front Physiol       Date:  2016-06-02       Impact factor: 4.566

7.  Regulated internalization of NMDA receptors drives PKD1-mediated suppression of the activity of residual cell-surface NMDA receptors.

Authors:  Xiao-Qian Fang; Haifa Qiao; Bradley R Groveman; Shuang Feng; Melissa Pflueger; Wen-Kuan Xin; Mohammad K Ali; Shuang-Xiu Lin; Jindong Xu; Florian Duclot; Mohamed Kabbaj; Wei Wang; Xin-Sheng Ding; Teresa Santiago-Sim; Xing-Hong Jiang; Michael W Salter; Xian-Min Yu
Journal:  Mol Brain       Date:  2015-11-19       Impact factor: 4.041

8.  Antiparkinsonian effects of the "Radiprodil and Tozadenant" combination in MPTP-treated marmosets.

Authors:  Anne Michel; Jean-Marie Nicolas; Sarah Rose; Michael Jackson; Peter Colman; Willy Briône; David Sciberras; Pierandrea Muglia; Dieter K Scheller; Martin Citron; Patrick Downey
Journal:  PLoS One       Date:  2017-08-30       Impact factor: 3.240

9.  Adenosine A2A Receptors Control Glutamatergic Synaptic Plasticity in Fast Spiking Interneurons of the Prefrontal Cortex.

Authors:  Amber Kerkhofs; Paula M Canas; A J Timmerman; Tim S Heistek; Joana I Real; Carolina Xavier; Rodrigo A Cunha; Huibert D Mansvelder; Samira G Ferreira
Journal:  Front Pharmacol       Date:  2018-03-20       Impact factor: 5.810

10.  Inhibition of Connexin 43 and Phosphorylated NR2B in Spinal Astrocytes Attenuates Bone Cancer Pain in Mice.

Authors:  Hui Yang; Hui Yan; Xin Li; Jing Liu; Shousong Cao; Baisheng Huang; Dong Huang; Lixiang Wu
Journal:  Front Cell Neurosci       Date:  2018-05-08       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.